Treatment of non-alcoholic fatty liver disease in outpatients

Abstract

Interest in non-alcoholic fatty liver disease (NAFLD) is caused by the prevalence of this disease in all population groups. NAFLD is reported to be the most common form of chronic liver disease worldwide.

Keywords

• неалкогольная жировая болезнь печени
• метаболический синдром
• инсулинорезистентность
• медикаментозная коррекция
• non-alcoholic fatty liver disease
• metabolic syndrome
• insulin resistance
• drug treatment